dalteparin has been researched along with Diseases, Metabolic in 1 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Selgas, R | 1 |
| Del Peso, G | 1 |
| Sánchez Villanueva, R | 1 |
| Aroeira, LS | 1 |
| Fernández Perpén, A | 1 |
| Ortiz, A | 1 |
| Ruiz Ortega, M | 1 |
| Sánchez-Tomero, JA | 1 |
| Martínez, J | 1 |
| Marrón, B | 1 |
| Bajo, MA | 1 |
1 other study available for dalteparin and Diseases, Metabolic
| Article | Year |
|---|---|
[Theoretical bases for the proposal of a randomized, controlled, open label clinical trial to assess the efficacy of adding bemiparin to the icodextrin solution in patients on peritoneal dialysis with peritoneal transport disorders [FRIAT-BEM-2005-01]].
Topics: Glucans; Glucose; Hemodialysis Solutions; Heparin, Low-Molecular-Weight; Humans; Icodextrin; Metabol | 2008 |